Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAJAN SAGGAR

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1255351854
CMS profile
11675
Location
LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$102,864.30

174 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 4 of 4; records 151–174 of 174 matching records. This page contains 24 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAJAN SAGGAR

NPI 1255351854 · CMS profile ID 11675

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–174 of 174 matching records. This page contains 24 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1255351854?year=2024&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAJAN SAGGAR, NPI 1255351854, CMS profile ID 11675. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–174 of 174 matching records. This page contains 24 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1255351854?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). RAJAN SAGGAR, NPI 1255351854, CMS profile ID 11675. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–174 of 174 matching records. This page contains 24 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1255351854?year=2024&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
RAJAN SAGGAR, NPI 1255351854, CMS profile ID 11675, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–174 of 174 matching records. This page contains 24 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1255351854?year=2024&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

174 matching records · $102,864.30 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 174 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–174 of 174.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
United Therapeutics Corporation $35.0003/14/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149460620 CMS
United Therapeutics Corporation $706.7503/14/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149475611 CMS
United Therapeutics Corporation $48.7203/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149475400 CMS
United Therapeutics Corporation $48.8903/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149475580 CMS
Actelion Pharmaceuticals US, Inc. $2.6703/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078869760 CMS
Actelion Pharmaceuticals US, Inc. $1.1703/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078869838 CMS
Actelion Pharmaceuticals US, Inc. $21.0203/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078869968 CMS
Actelion Pharmaceuticals US, Inc. $7.1403/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078870024 CMS
United Therapeutics Corporation $3,400.0003/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149462166 CMS
Bayer Healthcare Pharmaceuticals Inc. $34.0502/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086212151 CMS
United Therapeutics Corporation $21.0002/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149461842 CMS
United Therapeutics Corporation $43.9602/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149461914 CMS
United Therapeutics Corporation $174.2002/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149462092 CMS
Actelion Pharmaceuticals US, Inc. $25.8002/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078869736 CMS
Actelion Pharmaceuticals US, Inc. $3.1902/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078870180 CMS
Bayer Healthcare Pharmaceuticals Inc. $29.8002/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086112654 CMS
United Therapeutics Corporation $106.1402/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149462206 CMS
United Therapeutics Corporation $58.7201/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149460626 CMS
Actelion Pharmaceuticals US, Inc. $14,175.0001/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078869888 CMS
United Therapeutics Corporation $34.6501/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149463708 CMS
Bayer Healthcare Pharmaceuticals Inc. $28.8201/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086203271 CMS
Actelion Pharmaceuticals US, Inc. $24.0801/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078870084 CMS
Insmed, Inc. $140.3401/03/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089583300 CMS
Insmed, Inc. $69.7901/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089583324 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $53,716.68 73
PY2020 $10,377.57 21
PY2021 $17,007.60 36
PY2022 $66,034.97 129
PY2023 $81,177.43 172
PY2024 $102,864.30 174
PY2025 $148,940.64 198

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $540,932.61 13
PY2024 Principal investigator $729,538.27 22
PY2023 Principal investigator $805,447.19 25
PY2022 Recipient $2,629.09 4
PY2022 Principal investigator $333,953.01 28
PY2021 Principal investigator $87,694.00 25
PY2020 Principal investigator $65,383.84 8
PY2019 Principal investigator $255,147.02 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $77,829.62 12/31/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sotatercept When Added to Maximum Tolerated Background Therapy in Participants With Pulmonary Arterial Hypertension PAH World Health Organization WHO Functional Class FC III o No dispute reported 06/30/2026 1232917473
Principal investigator 1 Merck Sharp & Dohme LLC $118,580.19 12/31/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3, Randomized Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension PAH Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients No dispute reported 06/30/2026 1232936580
Principal investigator 1 Merck Sharp & Dohme LLC $323,216.40 12/31/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension PAH Therapy for the Treatment of PAH No dispute reported 06/30/2026 1232938822
Principal investigator 1 Liquidia Technologies, Inc. $252.00 12/09/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3 Open-label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients No dispute reported 06/30/2026 1208893996
Principal investigator 1 Liquidia Technologies, Inc. $252.00 12/09/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3 Open-label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients No dispute reported 06/30/2026 1208894000
Principal investigator 1 Liquidia Technologies, Inc. $190.00 12/04/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3 Open-label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients No dispute reported 06/30/2026 1208893992
Principal investigator 1 Liquidia Technologies, Inc. $252.00 12/04/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3 Open-label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients No dispute reported 06/30/2026 1208893998
Principal investigator 1 Liquidia Technologies, Inc. $314.86 12/04/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3 Open-label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients No dispute reported 06/30/2026 1208894002
Principal investigator 1 Liquidia Technologies, Inc. $321.00 12/04/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3 Open-label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients No dispute reported 06/30/2026 1208894004
Principal investigator 1 Liquidia Technologies, Inc. $2,205.00 12/04/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3 Open-label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients No dispute reported 06/30/2026 1208894026
Principal investigator 1 Liquidia Technologies, Inc. $3,654.00 12/04/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A Phase 3 Open-label, Multicenter Study to Evaluate the Long-term Safety and Tolerability of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients No dispute reported 06/30/2026 1208894036
Principal investigator 1 Merck Sharp & Dohme LLC $1,899.54 08/26/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension PAH Therapy for the Treatment of PAH No dispute reported 06/30/2026 1232938824
Principal investigator 1 United Therapeutics Corporation $11,966.00 01/22/2025 Covered Recipient Teaching Hospital
Ronald Reagan Ucla
A STUDY EVALUATING THE LONG-TERM EFFICACY AND SAFETY OF RALINEPAG IN SUBJECTS WITH PAH VIA AN OPEN-LABEL EXTENSION No dispute reported 06/30/2026 1242382146